echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > JPBA: Paiyu San reduces colitis in mice by regulating the intestinal flora and restoring the intestinal barrier function

    JPBA: Paiyu San reduces colitis in mice by regulating the intestinal flora and restoring the intestinal barrier function

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Intestinal barrier dysfunction and intestinal flora imbalance with excessive inflammation areOne of the reasons for the occurrence and acceleration of ulcerative colitis (UC)
    .
    Chinese medicine theory, UC invasive colon caused by the cold dampness
    appendicitis , often accompanied by hot and humid, blood stagnation and intestinalvascularischemia, its therapeutic application to heat, dampness, yang of the law
    .
    The traditional Chinese medicine prescription
    Paiyu San comes from"The Synopsis of the Golden Chamber", which is mainly composed of Citrus aurantium, Radix Paeoniae Alba and Platycodon grandiflorum.
    Studies have found that it has an
    anti-colitis effect, but itis unclear whetheritspreventiveeffect of UC is related to the intestinal flora
    .

    Intestinal barrier dysfunction.
    Intestinal barrier dysfunction.
    Intestinal flora imbalance with inflammation.
    Intestinal flora imbalance with inflammation.
    Ulcerative colitis (UC)Ulcerative colitis (UC)Ulcerative colitis appendicitis appendicitis vascular heat, dampness, yang heat, dampness, yang pus scattered pus scattered "Golden Chamber" anti-colitis anti-colitis prevention

    Objective: To explore the effect of Paiyusan extract on UC, to understand the mechanism of PNS in the treatment of UC , to provide a theoretical basis for its modern clinical application, and to reveal its related mechanism with intestinal flora
    .

    The mechanism of PNS in the treatment of UC The mechanism of PNS in the treatment of UC

    Method: Firstly, the main active components in PNS extract (PNS) were identified by ultra performance liquid chromatography quadrupole tandem time -of- flight mass spectrometry ( UPLC-Q-TOF-MS ) , and dextran sulfate was used.
    Sodium (DSS) induced UC mice (control group, DSS group-2.
    5% DSS aqueous solution, PNS low and high dose groups-PNS 0.
    36 g/kg/day and 1.
    44 g/kg/day, sulfasalazine group-SASP 0.
    42 g/kg/day), to explore the relevant mechanisms of PNS in the treatment of UC from the aspects of intestinal flora, intestinal barrier and TLR4/NF-κB signaling pathway
    .

    UPLC-Q-TOF-MS UPLC-Q-TOF-MS active ingredient identification active ingredient identification

    Results: 125 compounds were identified from PNS, including 42 flavonoids, 29 triterpenoids, 21 monoterpenoids, 11 polyphenols, 6 citrins, and alkaloids 5, 4 coumarin compounds and 7 other compounds
    .

    In vivo experimental results show that PNS treatment can reduce the weight loss and disease activity index of mice with DSS-induced colitis, prevent colon shortening, and reduce colonic histological inflammation , and PNS treatment has a dose-dependent protection against DSS-induced colitis Role
    .

    Reduce the histological inflammation of the colon Reduce the histological inflammation of the colon

    Tight junction protein (TJP) isthe main component tomaintain the intestinal barrier function
    .
    After modeling, the expression levels of claudin-1, occludin and ZO-1 proteins in colon tissue were significantly lower than those in the control group.
    High-dose PNS can significantly increase the expression levels of claudin-1, occludin and ZO-1 proteins.
    These results indicate that PNS It can regulate the expression of these genes and effectively alleviate the intestinal barrier damage induced by DSS in mice

    .

    Tight junction protein (TJP) Tight junction protein (TJP) intestinal barrier function intestinal barrier function

    Compared with the DSS group, PNS treatment can significantly reverse the decrease in the diversity of intestinal flora , inhibit the overgrowth of conditional pathogenic bacteria such as Oscillospiraceae and Helicobacter, while the intestinal flora of probiotics such as Romboutsia, Lactobacillus, Bifidobacterium and Akkermansia increases
    .
    In addition, PNS inhibits the intestinal TLR4/NF-κB signaling pathway by down-regulating TLR4, MyD88, p-NF-κB p65 and p-IκBα protein expression, and significantly improves colonic inflammation

    .

    PNS treatment can significantly reverse the decrease in intestinal flora diversity PNS treatment can significantly reverse the decrease in intestinal flora diversity

    Conclusion: PNS can effectively improve the DSS-induced colitis by regulating the intestinal flora , restoring the intestinal barrier function, weakening the TLR4/NF-κB signaling pathway , which may provide a new explanation for the anti-UC mechanism of PNS, and also for the regulation of traditional Chinese medicine.
    The intestinal microbiota plays a therapeutic role and
    provides an important reference

    .

    Regulate the intestinal flora.
    Regulate the intestinal flora.
    Attenuate the TLR4/NF-κB signaling pathway.
    Attenuate the TLR4/NF-κB signaling pathway.
    Traditional Chinese medicine plays a therapeutic role by regulating the intestinal microbiota.

    Literature source:

    Literature source:

    Wang K, Guo J, Chang X, et al.
    Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades [published online ahead of print, 2021 Dec 10].
    J Pharm Biomed Anal.
    2021;209:114529.
    doi:10.
    1016/j.
    jpba.
    2021.
    114529

    Wang K, Guo J, Chang X, et al.
    Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades [published online ahead of print, 2021 Dec 10].
    J Pharm Biomed Anal.
    2021;209:114529.
    doi:10.
    1016/j.
    jpba.
    2021.
    114529

     



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.